NDC 43063-818

Docusate Sodium with Sennosides

Docusate Sodium -sennosides

Docusate Sodium with Sennosides is a Oral Tablet, Coated in the Human Otc Drug category. It is labeled and distributed by Pd-rx Pharmaceuticals, Inc.. The primary component is Docusate Sodium; Sennosides A And B.

Product ID43063-818_835f748d-84e5-c2b2-e053-2991aa0a867e
NDC43063-818
Product TypeHuman Otc Drug
Proprietary NameDocusate Sodium with Sennosides
Generic NameDocusate Sodium -sennosides
Dosage FormTablet, Coated
Route of AdministrationORAL
Marketing Start Date2017-12-21
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart334
Labeler NamePD-Rx Pharmaceuticals, Inc.
Substance NameDOCUSATE SODIUM; SENNOSIDES A AND B
Active Ingredient Strength50 mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 43063-818-28

28 TABLET, COATED in 1 BOTTLE, PLASTIC (43063-818-28)
Marketing Start Date2017-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 43063-818-28 [43063081828]

Docusate Sodium with Sennosides TABLET, COATED
Marketing CategoryOTC monograph not final
Application Numberpart334
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2017-12-21
Marketing End Date2020-01-09

Drug Details

Active Ingredients

IngredientStrength
DOCUSATE SODIUM50 mg/1

OpenFDA Data

SPL SET ID:f12c6344-c59b-4b76-8b49-f971d7f08f14
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 998740
  • UPC Code
  • 0343063818282
  • NDC Crossover Matching brand name "Docusate Sodium with Sennosides" or generic name "Docusate Sodium -sennosides"

    NDCBrand NameGeneric Name
    43063-818Docusate Sodium with SennosidesDOCUSATE SODIUM -SENNOSIDES
    43063-958Docusate Sodium With SennosidesDocusate Sodium 50mg and Sennosides 8.6mg
    0536-4086SENEXON-SDOCUSATE SODIUM -SENNOSIDES
    0615-8083SENEXON-SDOCUSATE SODIUM -SENNOSIDES
    33261-749SENEXON-SDOCUSATE SODIUM -SENNOSIDES
    52959-675SENEXON-SDOCUSATE SODIUM -SENNOSIDES
    68788-9407SENEXON-SDOCUSATE SODIUM -SENNOSIDES

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.